Upload
dangdien
View
216
Download
2
Embed Size (px)
Citation preview
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Attachment E.1
Emissions to Air
Pfizer Cork Ltd., Inchera, Little Island, Cork
IPPCL Application
May 2007 Issue No: 2 45078720
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:11
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.3
Page i
CONTENTS
Section Page No
1. CHARACTERISATION OF EMISSIONS TO AIR ........................................................... 1
1.1. Introduction....................................................................................................................... 1 1.2. Requested Changes ........................................................................................................ 1 1.2.1. Boiler Fuel ........................................................................................................................ 1 1.3. Main Emissions ................................................................................................................ 2 1.4. Minor Emissions ............................................................................................................... 2 1.5. Potential Emissions.......................................................................................................... 2 1.6. Assessment of Emissions to Air regarding S.I. No. 394 of 2004 ..................................... 3
2. ABATEMENT OF EMISSION TO AIR............................................................................. 4
2.1. Introduction....................................................................................................................... 4 2.2. Description of Abatement................................................................................................. 6 2.2.1. Condensation ................................................................................................................... 6 2.2.2. Scrubbers ......................................................................................................................... 9 2.2.3. HEPA Filtration............................................................................................................... 11 2.2.4. Carbon Adsorption ......................................................................................................... 12
Appendix E.1.1: - List of Emissions to Air
Appendix E.1.2: - Drawings indicating Emission to Air
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:11
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 1
1. CHARACTERISATION OF EMISSIONS TO AIR
1.1. Introduction
Emissions to air from the Pfizer facility at Inchera comprise:
1. Emissions from steam raising boilers;
2. Main Emissions;
3. Minor emissions, i.e., point source emissions to air that are less than pre-
determined EPA thresholds;
4. Fugitive emissions; and
5. Potential emissions.
Subsequent sections provide an overview of all other major and minor emission points
including a description of the abatement technologies used.
A full list of all point source emissions is presented in Appendix E.1.1.
The location of all main emissions and minor emissions are depicted on drawing FSK-
2022 contained in Appendix E.1.2.
1.2. Requested Changes
1.2.1. Boiler Fuel
There are a total of two operational steam-raising boilers on the Pfizer site (A17 & A18).
Demand is normally met by one boiler modulating according to steam demand with other
boiler on standby. The duty/standby mode is rotated between boilers to provide for even
operational hours.
Currently, both boilers use natural gas only but Pfizer is considering the future use of light
fuel oil or diesel as an occasional substitute for natural gas. The emissions from the
boilers are considered ‘significant’ in the context of declaring the emissions for IPPC
licensing purposes since, should light fuel oil be burned, then all boiler rated input thermal
capacities are significantly larger than 250 kW considered as a ‘rule-of-thumb’ for
declaring such emissions.
A general air dispersion modelling report has been completed dealing with all major
emission sources on the site. The use of light fuel oil with a sulphur content of up to 0.2 %
was included in the assessment specifically to assess the air quality impacts of the
proposed use of oil, and allowing for impending legislation on the maximum content of
sulphur in fuel oils. The details of the modelling methodology and the model inputs and
outputs are contained within the report. The report concluded that even when running the
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:11
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 2
two boilers at full load using a light fuel oil with 0.2 % S1, no exceedance of the statutory
limits from SO2, NOx or PM10 is anticipated. The normal operational mode, i.e. only one
boiler running, and the use of a fuel oil with substantially less than 0.2 % S will result in
no significant change to air quality in the vicinity of the Pfizer site.
1.3. Main Emissions
In addition to the boilers described in Section 1.2.1 above, there are a total of 9 point
source main emissions on the Pfizer site. All emissions are derived from production and
the main pollutants are organic solvents and particulate matter with occasional emissions
of inorganic substances.
All of the main emissions currently being used have some form of abatement equipment
to ensure that the emissions to atmosphere are very significantly reduced and that they
meet the requirements of discharge standards set by the EPA. Details of the abatement
systems employed are presented in Section 3 of this Attachment.
Emission point A6 is currently not in use. Pfizer plans to provide abatement for this unit
to ensure that the required EPA standards for emissions are met should the emission
point be required. One option is to tie this emission point into additional abatement
equipment.
1.4. Minor Emissions
There are approximately 50 minor emissions to atmosphere from the Pfizer site. These
emissions contain only very small quantities of pollutants. These emissions can be
categorised as follows:
• Laboratory fumehoods;
• Very small boilers used for space heating;
• Storage tank vents; and
• Building or non-production system extraction systems.
1.5. Potential Emissions
Potential emission at Pfizer are those emissions that may occur in the event of an
event that may occur outside of normal set points or operational conditions. The main
sources of potential emissions are:
• Pressure relief valves lifting;
• Bursting disks rupturing;
1 Light fuel oil was used for modeling as this presents the worst case scenario, because light fuel oil usually has
higher sulphur content than diesel.
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:11
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 3
• Bypasses on abatement equipment.
A full list of all point source emissions is presented in Appendix E.1.1.
The location of all main emissions and minor emissions are depicted on drawing
FSK-2022 contained in Appendix E.1.2.
1.6. Assessment of Emissions to Air regarding S.I. No. 394 of 2004
Pfizer has carried out an assessment of the main emissions to air in respect of the
Schedule contained in S.I. No. 394 of 2004 (the revised Licensing Regulations).
The result of this assessment is presented in Table E.1.1.
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:11
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 4
2. ABATEMENT OF EMISSION TO AIR
2.1. Introduction
Pfizer has invested very significantly in emissions to air abatement. The abatement
systems employed are considered BAT for the nature of activities at Pfizer. In general,
the types of abatement may be summarised as follows:
Type of Abatement Target Pollutants
Primary and secondary
condensation
Condensable volatile organic solvents
Scrubbers:
- Water
- Caustic
- Hypochlorite
Miscible volatile organic solvents
Acid fumes, miscible volatile organic compounds
and soluble inorganic compounds
Deactivation of an active ingredient
HEPA Filtration & Filter Pad Particulate matter
Carbon adsorption Volatile organic solvents and including chlorinated
organic solvents.
Figure E.1.1 depict, very simply, the interconnection between the various means of
abatement equipment and the main emission points serviced by the abatement systems.
Excluded from Figure E.1.1 are the condensers, of which there are many and which are
located local to the process equipment within the production building
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:11
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 5
For in
spec
tion p
urpo
ses o
nly.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:11
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 6
2.2. Description of Abatement
2.2.1. Condensation
Condensation uses the principle of cooling condensable vapours to below their dew point
at process conditions so that the vapours condense to liquid which then drops out of the
gas stream being treated. The key pollutants targeted at Pfizer are condensable organic
solvents used in production and that are typically vented off from reactors, dryers and
other processing equipment.
The target compounds have differing thermodynamic properties and so will condense out
of the gas stream being treated at different temperatures and at different rates. Other
factors, such as the system pressure and condenser design, will also effect the efficiency
of condensation.
At Pfizer, there are different condenser layouts and designs employed and these systems
are contained within the production building and close to the equipment which they serve.
All condensation employed is carried out as indirect cooling with no intimate contact
between the cooling medium and the gas stream being cooled.
Condensation systems employed may be broadly classified as:
- Primary condensation, which uses water as the cooling medium, typically
cooling tower water at between approximately 18 C and 23 C;
- Secondary, or low temperature, condensation using glycol/water mix or
methanol/water mixes at temperatures approaching –10 C. The cooling
medium in each case is supplied from a closed loop refrigeration system
located in the utilities buildings.
For some processes, only primary condensation is used and in others both primary
condensation followed in series by secondary condensation. The latter, operating at a
much lower cold side temperature, will achieve very high rates of condensation of those
condensables that have not been removed in primary condensation.
Given the multi-product nature of Pfizer activities, the condenser systems on site are
arranged in such a manner that a high degree of flexibility in choosing condenser layout
is achieved.
Condensers used at Pfizers are generally one of two designs:
1. Shell and tube heat exchangers;
2. Graphite block heat exchangers.
Both types of condenser operate on a similar principle: - the gas is indirectly cooled by a
coolant.
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:11
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 7
For shell and tube exchangers, the cooling medium flows through banks of metal tubes.
These tubes are bundled inside an outer shell through which the gas stream to be cooled
flows. As the warm gas contacts the cold tubes, the gas flow is cooled and liquid VOC’s
drop out and flow from the condenser shell to the receiving vessel.
Graphite exchangers are more suitable for primary condensation and so are very widely
used for reactor overhead condensers. The main reason for employing block type
graphite heat exchangers is their great flexibility. They can be used for all heat transfer
and mass transfer process involving corrosive media. Heat transfer takes place in solid
graphite blocks with a crosswise arrangement of drilled flow passages for the product and
service side. The size of the graphite blocks and the passage diameters vary according to
the application. Several graphite blocks can be assembled to form a column, which
provides the required heat transfer area in a single unit.
Condensers at Pfizers are generally only the first stage in abatement trains and are
viewed more not as abatement, rather as an important functional process unit operation
rather than abatement. This is particularly true for primary condensation where the
condensers are arranged for different process operations in a reactor, primarily:
- reflux (where the condensed solvent is returned directly to the reactor), and
- distillations (where the solvent is removed from the reactor and routed to a
receiver. From the receiver, the solvent is pumped to waste solvent storage
tanks).
A typical arrangement of primary and secondary condensers for a reactor system at
Pfizer is provided in Figure E.1.2.
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:11
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 8
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:12
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 9
2.2.2. Scrubbers
Several scrubbers are employed at the Pfizer site. All scrubbers share common features
as follows:
- They are packed scrubbers. The packing, varying in design, substantially
increases the intimate mixing of the gas and liquid streams which then drives
contaminant removal from the gas stream to the liquid stream;
- The scrubbers operate on a counter flow basis: - i.e., the gas stream being
treated flows against the scrubber liquor flow in a counter-current flow. This is
considered the most efficient means of contaminant removal from the gas
stream;
- The scrubbers all have scrubber liquor sumps from which the scrubber liquor
is continuously recirculated by pumping through the scrubber column.
Occasionally, scrubber liquor is bled as a process effluent to the wastewater
treatment plant and the lost liquor is topped up to retain a constant sump
level.
A ‘caustic scrubber’ utilises a caustic scrubber solution (pH about 12). For those
processes that may emit acid fumes into the header system, the header used to take the
fumes is directed to the caustic scrubber. The caustic content of the scrubber liquor
converts the acid fumes to soluble salts in the scrubbing liquor, thus removing them from
the header extraction flow. The scrubber liquor in the caustic scrubber is continuously
monitored for pH and if the pH falls below a certain set point, then caustic solution is
automatically dosed into the scrubber solution, or liquor, to regain the pH.
A ‘water scrubber’ uses water at neutral pH. These scrubbers are designed primarily to
remove soluble volatile organic compounds but can also remove trace entrained
particulate matter and soluble inorganic compounds from the same gas flow should they
be present.
A typical scrubber flow diagram is provided in Figure E.1.3.
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:12
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 10
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:12
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 11
2.2.3. HEPA Filtration
High Efficiency Particulate Absorbing (HEPA) filters are capable of very high (typically
greater than 99.9%) removal efficiencies of very fine dust particulate matter.
At Pfizer, these filters are employed in areas where process dust, mainly containing
active pharmaceutical dust, is likely to be generated (e.g., during milling and packing).
These filters are composed of a mat of randomly arranged fibers. Key metrics affecting
function are fiber density and diameter, and filter thickness. The common assumption that
a HEPA filter acts like a sieve where particles smaller than the largest opening can pass
through is incorrect. HEPA filters are designed to target much smaller pollutants and
particles are mainly trapped (they stick to a fiber) by one of the following three
mechanisms:
1. interception, where particles following a line of flow in the airstream come within
one radius of a fiber and adhere to it;
2. impaction, where larger particles are unable to avoid fibers by following the
curving contours of the airstream and are forced to embed in one of them directly;
this increases with diminishing fiber separation and higher air flow velocity;
3. diffusion, an enhancing mechanism which is a result of the collision with gas
molecules by the smallest particles, especially those below 0.1 µm in diameter,
which are thereby impeded and delayed in their path through the filter.
The initial filter air flow resistance and final filter air flow resistance are typically measured
as presure drop across the filters.
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:12
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 12
2.2.4. Carbon Adsorption
There is a carbon adsorption system on the Pfizer site.
A simplified flow diagram of the carbon adsorption design is presented in Figure E.1.4.
2.2.4.1. The Carbon System
The carbon adsorption system installed on the Pfizer site is the main abatement
equipment for emissions to air and may be considered a central system for emissions to
air. That is, the system is connected to an incoming header which in turn takes extraction
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:12
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 13
gas streams from various production facilities on the site and from some organic solvent
storage tanks in the Tank Farm 3.
The incoming gas flow containing gaseous organic solvents is passed through an
adsorber bed. The main organic solvent in the incoming gas stream is dichloromethane
(DCM). The volatile organic compounds (VOCs) are adsorbed onto the activated carbon
and retained within the vessel. The exhaust gas is discharged through the exhaust stack
to the environment.
Following the completion of the adsorption cycle, the activated carbon is regenerated by
passing low pressure steam through the bed in a counter flow direction. The VOCs
retained by the activated carbon are stripped from the carbon and carried out of the
adsorber.
The condensed steam/solvent mixture from the carbon adsorber flows to the decanter
where the liquid separates into 3 phases. Water and light solvents go from stage 1 to
stage 2 by overflowing an internal baffle as the level rises in stage 1. Also in stage 1 there
is an automatic valve and level switch in place in order to stop flow out of the first
separation chamber in the event of the heavy solvent being depleted or not present. This
is done by using a ball float which has a specific density equal to that of DCM. The valve
is opened when the ball float hits the upper level, pumping heavy solvents to
compartment 3 and closes when the ball hits the lower level.
In the second stage, the light solvents are separated from the water phase by the light
solvents overflowing an internal baffle as the level rises into stage 3. The water
containing dissolved solvents flows through an adjustable seal loop to the fourth stage
where it is pumped to the stripper feed tank FA-76. The light and heavy solvents collected
in stage 3 are pumped to the waste solvent tank ML-304.
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:12
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Page 14
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:12
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Appendix E.1.1 – List of Emissions to Air
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:12
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:12
Attachment E.1 Emissions to Air Pfizer Cork Limited, Inchera, IPPCL Application
Attachment E.1 Emissions to Air - Main Text_Final.doc
Appendix E.1.2 – Drawings indicating
Emission to Air
For
insp
ectio
n pur
pose
s only
.
Conse
nt of
copy
right
owne
r req
uired
for a
ny ot
her u
se.
EPA Export 25-07-2013:21:49:12